Jussi J Kangasmetsa

This inventor holds 16 USPTO granted patents and 5 published patent applications, plus 6 CIPO patents and 8 EPO patents. Top assignees: Allergan, Inc., Medivir Ab. Active years: 2011-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jussi J Kangasmetsa. Retrieved from https://idiyas.com/inventor/jussi-j-kangasmetsa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 6 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Safron Walden, GB (2015 - 2016)
Cambridge, GB (2016 - 2017)
Essex, GB (2011 - 2021)

Company Filing History:

Years Active: 2011-2021

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10988474 - Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response (2021-04-27),

2. 10392382 - Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response (2019-08-27),

3. 9657018 - Antagonists acting at multiple prostaglandin receptors for the treatment of inflammation (2017-05-23),

4. 9567328 - Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response (2017-02-14),

5. 9522890 - Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response (2016-12-20),

6. 9422273 - Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response (2016-08-23),

7. 9394284 - Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response (2016-07-19),

8. 9365569 - Antagonists acting at multiple prostaglandin receptors for the treatment of inflammation (2016-06-14),

9. 9090566 - Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response (2015-07-28),

10. 9085567 - Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response (2015-07-21),

11. 9035071 - Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response (2015-05-19),

12. 8969589 - Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response (2015-03-03),

13. 8859606 - Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response (2014-10-14),

14. 8653118 - Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response (2014-02-18),

15. 8492424 - Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response (2013-07-23),

Title: Jussi J Kangasmetsa: Innovator in Anti-Inflammatory Compounds

Introduction

Jussi J Kangasmetsa is a notable inventor based in Essex, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act on multiple prostaglandin receptors. With a total of 16 patents to his name, his work has the potential to impact the treatment of various receptor-mediated diseases.

Latest Patents

One of his latest patents focuses on compounds that provide a general anti-inflammatory response. The invention details a compound represented as a 1-({halo-2-[(2-hydrocarbyl or substituted hydrocarbyl)oxy]phenyl}methyl)-(fused bicyclic nitrogen heteroaryl) carboxylic acid or an ester or sulfonamide thereof. The compounds may be administered to treat diseases or conditions mediated by DP, FP, EP1, TP, and/or EP4 receptors.

Career Highlights

Throughout his career, Jussi has worked with prominent companies in the pharmaceutical industry, including Allergan, Inc. and Medivir AB. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Jussi has collaborated with notable professionals in his field, including Jose L Martos and David Frederick Woodward. These collaborations have likely enriched his research and development efforts.

Conclusion

Jussi J Kangasmetsa is a distinguished inventor whose work in anti-inflammatory compounds showcases his commitment to advancing medical science. His contributions continue to pave the way for new treatments in the pharmaceutical industry.

Profile summary based on public USPTO records.